About MDxHealth
Molecular Diagnostic Solutions for Prostate Cancer
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Irvine, CA
- Founded
- 2003
- Company type
- Public Company
Mdxhealth is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The company's tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, and prediction of response to a specific therapy. The Company's European headquarters are in Herstal, Belgium, with laboratory operations in Nijmegen, The Netherlands, and US headquarters and laboratory operations based in Irvine, California.
Specialties
- Molecular Diagnostics
- Methylation
- Cancer
- Next Generation Sequencing
- pharmaceutical and diagnostic products
- and medical devices
Company locations
15279 Alton Parkway Suite 100, Irvine, CA 92618, US
Rue d'Abhooz, 31, Herstal, Flanders 4040, BE
Harelbekestraat 72, 3de verdieping, Gent 9000, BE
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
Business areas
- Health Diagnostics
- Medical Device
- Biotechnology
On LinkedIn
- Followers
- 8,592
- People linked to this company
- 320
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Funding raised
169,375,489 USD
Total reported by Crunchbase, in US dollars. This is funding raised, not company revenue or valuation.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.